POC SARS-CoV-2 Diagnostic PCR Device Comparison to FDA Approved Reference PCR Test

NCT04981769 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2021-07-29

No results posted yet for this study

Summary

Study will assess sensitivity and specificity of AnavasiDx POC PCR device for detection of Covid-19 in patients presenting for testing a clinical sites.

Conditions

  • Covid19

Interventions

DIAGNOSTIC_TEST

Covid-19 test

PCR Covid-19 test

Sponsors & Collaborators

  • Anavasi Diagnostics

    lead INDUSTRY

Eligibility

Min Age
2 Years
Max Age
125 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-08-02
Primary Completion
2021-09-30
Completion
2021-11-30
FDA Device
Yes

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04981769 on ClinicalTrials.gov